- IBM は、失明の主要原因にうまく検出 深い学習 を使用します。|IBM uses deep learning to better detect a leading cause of blindness
TranslateApiException: Cannot find an active Azure Market Place Translator Subscription associated with the request credentials. : ID=1446.V2_Json.Translate.33CA207B
IBM on Thursday announced its latest breakthrough in combating eye disease, with new research methods that could help doctors diagnose and classify diabetic retinopathy (DR). DR is a complication of diabetes and one of the leading causes of blindness in the US. Using deep learning and visual analytics technology, IBM researchers were able to classify the severity of patients’ diabetic retinopathy (DR) with 86 percent accuracy. The method takes just 20 seconds to identify and classify legions, which could help more doctors screen more patients. Currently, diabetes patients are screened for DR by an expert clinician, in an often manual and time-intensive process.